EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

AAV- based vector improvements unrelated to capsid protein modification

Ekaterina M Shitik, Igor K Shalik, Dmitry V Yudkin

Frontiers in Medicine · 03.02.2023 · 10

DOI: 10.3389/fmed.2023.1106085 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Medicine, online erschienen am 03.02.2023. Verfasst von Ekaterina M Shitik und 2 weiteren Autor:innen. Beteiligte Einrichtung: Federal Scientific and Technical Program on the Development of Genetic Technologies, State Research Center of Virology and Biotechnology "Vector", Ro…. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant adeno-associated virus (rAAV) is the leading platform for delivering genetic constructs in vivo . To date, three AAV-based gene therapeutic agents have been approved by the FDA and are used in clinical practice. Despite the distinct advantages of gene therapy development, it is clear that AAV vectors need to be improved. Enhancements in viral vectors are mainly associated with capsid protein modifications. However, there are other structures that significantly affect the AAV life cycle and transduction. The Rep proteins, in combination with inverted terminal repeats (ITRs), determine viral genome replication, encapsidation, etc. Moreover, transgene cassette expression in recombinant variants is directly related to AAV production and transduction efficiency. This review discusses the ways to improve AAV vectors by modifying ITRs, a transgene cassette, and the Rep proteins.

Schlagwörter

Stichwörter der Autor:innen

Rep proteinsa transgene cassetteadeno-associated virusgene therapyinverted terminal repeats

Autor:innen und Institutionen

  • Federal Scientific and Technical Program on the Development of Genetic Technologies, State Research Center of Virology and Biotechnology "Vector", Rospotrebnadzor, World-Class Genomic Research Center for Biological Safe…

Zitieren

APA

Shitik, E. M., Shalik, I. K., & Yudkin, D. V. (2023). AAV- based vector improvements unrelated to capsid protein modification. Frontiers in Medicine, 10. https://doi.org/10.3389/fmed.2023.1106085

Vancouver

Shitik EM, Shalik IK, Yudkin DV. AAV- based vector improvements unrelated to capsid protein modification. Frontiers in Medicine. 2023;10. doi:10.3389/fmed.2023.1106085

BibTeX
@article{Shitik2023,
  author = {Shitik, Ekaterina M and Shalik, Igor K and Yudkin, Dmitry V},
  title = {AAV- based vector improvements unrelated to capsid protein modification},
  journal = {Frontiers in Medicine},
  year = {2023},
  volume = {10},
  doi = {10.3389/fmed.2023.1106085}
}
Kostenlos starten →